Absstract of: US2023146295A1
0000 Embodiments herein relate to an implant for insertion into a patient. The implant comprises a plurality of unit cells arranged to form a three-dimensional lattice structure, the three-dimensional structure comprising a resting volume of the implant. The plurality of unit cells are arranged to form a porous network of the three-dimensional structure, and wherein the three-dimensional structure is a reversibly compressible three-dimensional structure, wherein a bulk porosity of the three-dimensional structure of the implant is at least 50%. Also disclosed is a method of tissue reconstruction or tissue augmentation. The method comprises implanting into the body of a subject an implant of the disclosure.
Absstract of: AU2020239771A1
Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.
Absstract of: US20260252172A1
An electrocorticographic interface device includes a flexible thin-film electrode array formed on a biocompatible substrate such as polyimide, the electrode array having a plurality of recording electrodes and interconnect lines patterned on the biocompatible substrate, and the flexible thin-film electrode array further includes an array of perfusion holes distributed across the biocompatible substrate.
Absstract of: US2015123813A1
0001 Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.
Absstract of: WO2025164130A1
Provided are: a curable composition for three-dimensional stereolithography, which contains 100 parts by mass of a polymerizable monomer component (A), 40-400 parts by mass of an inorganic filler (B), 0.01-5 parts by mass of a photoinitiator (C), and 0.01-2.5 parts by mass of an activation light absorber (D), and in which 10-90 mass% of the inorganic filler (B) is contained as an organic-inorganic composite filler (E), the value of light scattering index Sc serving as an index of the proportion of light scattered laterally when being irradiated with activation light is 10% or less, and the rate of transmission for activation light in a state prior to being optically cured is 1-50%; and a method for producing the curable composition for three-dimensional stereolithography. The present invention also provides a method for producing a three-dimensional stereolithographic product and a method for producing a dental restoration article, in both of which said curable composition for three-dimensional stereolithography is used.
Absstract of: EP4595873A1
0001 An intravascular tissue analysis system (100) comprises one or more processors (110) configured to: receive optical data (120) representing an optical property of an intravascular tissue region (130) over one or more wavelength intervals; analyze the optical data (120) to determine i) a blood clot component content (140) of the intravascular tissue region (130), and ii) a lipid content (150) of the intravascular tissue region (130); and output an indication of the blood clot component content and the lipid content, and/or an indication of one or more tissue composition parameters derived therefrom.
Absstract of: WO2025160144A1
Disclosed are devices, systems, and techniques for evaluating position support for a medical device. The method includes performing a movement evaluation of one or more extremities of a patient associated with the medical device, determining, using at least one computer processor, passive movement of one or more muscles of the patient during the movement evaluation, and determining a fixation plan for fixing at least a portion of the medical device to one or more anatomical tissues of the patient based, at least in part, on the passive movement of the one or more muscles.
Absstract of: WO2025141425A1
A bioprinted liver model with a vascular system consisting of layers and comprising at least one flow channel in which: the first two layers forming the base of the model are 100% filled with bioink, and wherein layer 1 is positioned at an angle of 0° to the flow channel and layer 2 is positioned at an angle of 90° to the flow channel, the inner layers of the model are filled from 20% to 100% with bioink, wherein the inner layers comprise a centrally located at least one flow channel, the perimeter of which is printed with 100% filling and in which every inner layer is arranged at an angle of 60° with respect to the previous layer, the last two layers enclosing the model: the penultimate and the last layer are 100% filled with bioink and wherein the penultimate layer is arranged at an angle of 0° with respect to the flow channel and the last layer is arranged at an angle of 90° with respect to the flow channel, wherein the bioink used is based on natural polymers, synthetic polymers, methacrylated derivatives of natural polymers or mixtures thereof. A method for manufacturing the liver model and the use thereof.
Absstract of: WO2025137128A1
The present disclosure provides polymerizable composition that can produce desirable stain resistant polymeric materials, polymer compositions, and/or photo-curable resins. Further provided herein are methods of producing polymerizable compositions, resins, devices, and polymeric materials. Also provided herein are methods of using polymerizable compositions, resins, and polymeric materials for the fabrication (e.g., via 3D printing) of medical devices, such as orthodontic appliances.
Absstract of: KR103010689B1
본 개시의 일 실시예에 따라, 컴퓨팅 장치에 의해 수행되는 환자의 상태를 예측하는 방법이 개시된다. 상기 방법은 상기 컴퓨팅 장치에 포함된 적어도 하나의 프로세서가, 복수의 측정 항목에 대한 입력 데이터를 수신하는 단계; 및 상기 입력 데이터를 예측 모델에 입력하여 예측 결과를 산출하는 단계를 포함하고, 상기 예측 모델은, 상기 입력 데이터 중 시계열 데이터를 처리하는 제1 경로 및 상기 입력 데이터 중 정적 데이터를 처리하는 제2 경로를 포함하며, 상기 제1 경로의 출력과 상기 제2 경로의 출력에 기초하여 상기 예측 결과를 산출할 수 있다.
Absstract of: WO2025038830A1
Additive manufacturing methods, additive manufacturing systems (100), support material for additive manufacturing, and products thereof are provided. For example, the additive manufacturing methods includes depositing a structure material into a support material (108) based on a first computer model of an object, thereby forming a first portion of the object in the support material. The structure material exhibits a viscosity in a range of 1 mPa*s to 5000 mPa*s (1 cP to 5,000 cP) at 25 degrees Celsius. The support material exhibits a density in a range of 1.05 g/mL to 3 g/mL. The method includes repeating the depositing of the structure material as necessary to additively form the object.
Absstract of: WO2024263308A1
The present discloser provides methods and systems related to a medication container that may be locked using a locking mechanism. In one exemplary method, a request from a user may be received by a medication provider for a medication. The medication may be placed in a medication container with a locking mechanism that is operable to lock and unlock the medication container. The medication container may be locked using the locking mechanism. The locked medication container with the medication within may be provided to the user. Subsequent to providing the locked medication container to the user, a request may be received from the user to access the medication in the medication container. A credential may be sent to the user that is usable, via the locking mechanism, to unlock the medication container. The user may then input the credential into the locking mechanism to unlock the medication container and access the medication therein.
Absstract of: KR103009891B1
0001a 본 개시의 방사선그리드는 차폐체기판을 포함하고, 상기 차폐체기판은 방사선투과성의 제 1 커버기판, 방사선투과성이고, 상기 제 1 커버기판과 마주보며, 상기 제 1 커버기판과의 사이에 공간을 형성하는 제 2 커버기판, 및 상기 제 1 커버기판과 상기 제 2 커버기판 사이의 공간에 위치하고, 전압에 기초하여 정렬되는 방사선비투과성의 물질을 포함하는 차폐유체를 포함하고, 상기 제 1 커버기판 및 상기 제 2 커버기판 중 적어도 하나는 상기 방사선비투과성의 물질을 정렬시키기 위한 전극을 포함한다.
Absstract of: CN122658662A
0001 本申请公开了一种血液透析患者蛋白能量消耗评估方法、系统、设备、存储介质及产品,涉及医疗信息学与临床营养辅助决策技术领域,该方法包括获取患者的基本信息;根据所述患者的基本信息,对患者的多个维度进行判定,得到维度满足数;将所述主观综合营养评估分级与所述营养不良炎症评分别进行分量化,得到主观综合营养评估等级量化分值和营养不良炎症评分量化分值;根据主观综合营养评估等级量化分值、营养不良炎症评分量化分值、各维度判定值、炎症附加分及相位角附加分,得到综合风险分值;根据所述综合风险分值、所述维度满足数、所述主观综合营养评估分级和所述营养不良炎症评分,判定蛋白能量消耗状态。本申请能够实现对蛋白能量消耗的精准化评估。
Absstract of: CN122642851A
0001 本申请公开了一种核心体温测量方法、系统及体温测量设备,属于体温测量技术领域。该方法包括:在主动加热开始后的预设时间窗口内,获取加热侧温度、皮肤侧温度、皮肤侧压力以及加热驱动信息;根据皮肤侧压力,计算加热探头与目标对象的皮肤之间的界面热阻;根据加热侧温度、皮肤侧温度以及加热驱动信息,基于非稳态热平衡模型,计算人体侧等效热流密度;根据皮肤侧温度、界面热阻以及所述人体侧等效热流密度,确定目标对象的非稳态核心体温。上述方案无需等待探头与皮肤达到稳态热平衡即可快速获得核心体温,在保证核心体温的测量准确性的同时提高了核心体温测量速度。
Absstract of: KR20260130174A
본 발명은 이중극 전기방사와 4축 3D 프린팅을 활용한 인공 혈관용 스캐폴드의 제조 방법으로, 보다 구체적으로는 고분자 용액을 이중극 전기방사하여 생성되는 나노 섬유를 희생재료에 균일하게 배열시켜 내강이 형성된 나노 섬유 구조를 제조하고, 제조된 나노 섬유 구조에 4축 3D 프린터를 활용하여 나선형 패턴을 형성시킴으로써 조직 재생에 유리하면서 내구성이 향상된 인공 혈관용 스캐폴드를 제조할 수 있는 방법에 관한 것이다.
Absstract of: CN122643107A
0001 本发明公开了一种基于激光诱导石墨烯电极阵列的纸基微流控智能伤口监测绷带及其制备与信号处理方法。绷带包括海藻酸钙/氧化锌抗菌基底、蜡印纸基侧向层析微流控通道层、CO<2>激光直写LIG多功能电极阵列、比色指示区、NFC无线通信模块和银纳米线电控药物释放模块。LIG电极经酶固定化和化学修饰后分别检测尿酸、乳酸、葡萄糖和pH值;纸基比色盘检测细菌蛋白酶和TNF‑α;NFC射频场供能实现无电池工作。内置信号处理方法包括温度补偿、交叉干扰消除、多参数融合感染风险评分和双阈值闭环给药决策。制备工艺以激光直写、丝网印刷和离子交联为主,材料成本低,工艺绿色环保,适用于慢性伤口的家庭和临床闭环监测与治疗。
Absstract of: CN122642837A
本申请涉及麻醉监测技术领域,公开了一种儿童麻醉后苏醒的监测方法、系统、终端及介质,所述方法包括:获取目标儿童在进行麻醉后的视频数据、音频数据和生理数据;根据所述视频数据、所述音频数据和所述生理数据分别进行特征提取,得到面部与肢体特征、音频特征和生理特征;根据所述视频数据、所述面部与肢体特征、所述音频特征和所述生理特征进行单模态评分,得到评分汇总;根据所述评分汇总,得到所述目标儿童的苏醒总分和预警标志,并根据所述苏醒总分和所述预警标志向医护人员进行预警。本申请通过多模态特征融合,及时发现儿童苏醒或并发症异常,提供实时连续统一的苏醒状态评估,降低漏报率和误报率,提高儿童麻醉后苏醒的监测效果。
Absstract of: CN122654670A
0001 本发明涉及认知训练与神经退行性疾病干预技术领域,且公开了一种阿尔茨海默病患者情景记忆提取训练方法,包括以下步骤:将患者情景记忆分解为时间锚点、空间场景、人物关系、情感状态和事件主线五个维度,为各维度建立特征向量,采用图神经网络构建非线性情景关联图谱,其中记忆片段为图节点,通过注意力机制计算节点间多维关联强度作为边权重,得到分层记忆库;构建多模态感官刺激编码器。该阿尔茨海默病患者情景记忆提取训练方法的目的是为了解决现有技术采用线性时序处理无法有效应对阿尔茨海默病患者时序混乱和记忆片段化、且缺乏多模态自适应刺激与动态难度调节机制导致训练效果受限的问题。
Absstract of: CN122647224A
本发明涉及口腔修复材料技术领域,公开了一种氧化锆义齿精准智造及快速戴牙工艺,包括:获取数字切削的半烧结义齿初胚;置于烧结炉进行三阶等温相变烧结,依次经过动态排胶、基于几何特征参数设定的等温表面扩散以及致密化烧结;在随炉降温至特定温度窗口时通入湿空气,使水分子解离吸附生成表面羟基;随后立即通入极干燥气体强制置换排空水汽并降至室温。临床戴牙时,不对成品义齿进行椅旁喷砂预处理,直接涂布含磷酸酯基团的树脂水门汀完成交联固化。本发明利用等温驻留消除热应力降低收缩形变,原位气相活化建立高强度化学粘接并简化操作,强制扫气避免水热降解,实现了义齿的精确就位与快速稳定粘接。
Absstract of: WO2016172699A1
Methods of preparing a delivery system are described. Each method uses a first and second printing materials. The second printing material contains an active material such as a fragrance, flavor, malodor counteracting agent, and mixture thereof.
Absstract of: US20260253694A1
0000 A system, method and wireless earpieces for populating an electronic medical record utilizing wireless earpieces. The sensor measurements are analyzed. The sensor measurements are associated with the electronic medical record of the user. The electronic medical record of the user is populated with the sensor measurements. Communications including the electronic medical record are communicated.
Absstract of: US20260250614A1
0000 A novel vascular tissue model is disclosed. The model uses a rigid 3D printed scaffold. This scaffold includes one or more scaffold microfluidic channels, two or more inlets, and a central chamber. The central chamber contains a hydrogel, and the hydrogel includes a hydrogel microfluidic channel.
Absstract of: US20260253722A1
0000 Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
Nº publicación: US20260248438A1 27/08/2026
Applicant:
OURA HEALTH OY [FI]
Oura Health Oy
Absstract of: US20260248438A1
Methods, systems, and devices for atrial fibrillation (AFib) detection are described. A method may include acquiring physiological data collected from a user via a wearable ring device, the physiological data including temperature data and motion data, and identifying that a measurement trigger condition for AFib has been satisfied based on the temperature data satisfying a temperature threshold and the motion data satisfying a motion threshold. The method may include sampling photoplethysmogram (PPG) data for the user via the wearable ring device based on identifying satisfaction of the measurement trigger condition, and classifying one or more AFib states based on the sampled PPG data. The method may further include causing a GUI of a user device to display an indication of the one or more AFib states.